Cognition Therapeutics, Inc. (CGTX)
USD 0.35
(10.74%)
USD 0.35
(10.74%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | - | - | - | - | - |
| Cost of Revenue | 252 Thousand | 235 Thousand | 93 Thousand | 98 Thousand | 81 Thousand |
| Gross Profit | -252 Thousand | -235 Thousand | -93 Thousand | -98 Thousand | -81 Thousand |
| Operating Expenses | 50.72 Million | 21.33 Million | 11.15 Million | 6.55 Million | 4.66 Million |
| Selling, General and Administrative Expenses | 13.52 Million | 13.22 Million | 10.02 Million | 4.52 Million | 3.45 Million |
| Research and Development Expenses | 37.19 Million | 30.32 Million | 18.57 Million | 12.88 Million | 14.37 Million |
| Other Expenses | - | -22.21 Million | -17.44 Million | -10.85 Million | -13.16 Million |
| Cost and Expenses | 50.72 Million | 21.33 Million | 11.15 Million | 6.55 Million | 4.66 Million |
| Operating Income | -50.72 Million | -43.55 Million | -28.59 Million | -17.4 Million | -17.83 Million |
| Interest Expense | - | 28 Thousand | 893 Thousand | 1.75 Million | 1.02 Million |
| Income Tax Expense | - | -22.15 Million | -1.43 Million | 2.23 Million | 2.11 Million |
| Earnings before Tax | -25.78 Million | -21.39 Million | -11.71 Million | -7.83 Million | -4.84 Million |
| Net Income | -25.78 Million | 757 Thousand | -10.28 Million | -10.07 Million | -6.95 Million |
| Earnings Per Share Basic | -0.86 | 0.03 | -0.46 | -0.46 | -0.32 |
| Earnings Per Share Diluted | -0.86 | 0.03 | -0.46 | -0.46 | -0.32 |
| Weighted Average Shares Outstanding | 29.98 Million | 28.99 Million | 22.23 Million | 21.93 Million | 21.93 Million |
| Weighted Average Shares Outstanding (Diluted) | 30.02 Million | 28.99 Million | 22.23 Million | 21.93 Million | 21.93 Million |
| Gross Margin | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - |
| Profit Margin | - | - | - | - | - |
| EBITDA | -25.5 Million | -21.13 Million | -13.38 Million | -5.98 Million | -3.49 Million |
| Earnings Before Tax Margin | - | - | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | 372 Thousand | - | - | - |
| Cost of Revenue | 67 Thousand | 58 Thousand | 66 Thousand | 252 Thousand | 65 Thousand | 61 Thousand |
| Gross Profit | -67 Thousand | -58 Thousand | 306 Thousand | -252 Thousand | -65 Thousand | -61 Thousand |
| Operating Expenses | 14.61 Million | 14.04 Million | 15.12 Million | 50.47 Million | 7.06 Million | 4.89 Million |
| Selling, General and Administrative Expenses | 3.03 Million | 3.49 Million | 3.52 Million | - | 3.07 Million | 3.32 Million |
| Research and Development Expenses | 11.57 Million | 10.55 Million | 11.6 Million | - | 11.66 Million | 8.49 Million |
| Other Expenses | 333 Thousand | 244 Thousand | 287 Thousand | - | 314 Thousand | 172 Thousand |
| Cost and Expenses | 14.67 Million | 14.1 Million | 15.18 Million | 50.72 Million | 7.06 Million | 4.89 Million |
| Operating Income | -14.67 Million | -14.1 Million | -15.18 Million | -50.72 Million | -14.74 Million | -11.81 Million |
| Interest Expense | 7000.00 | 10 Thousand | 9000.00 | -27 Thousand | 2000.00 | 6000.00 |
| Income Tax Expense | - | 14.72 Thousand | 2.29 Million | - | 316 Thousand | 178 Thousand |
| Earnings before Tax | -7.04 Million | -9.15 Million | -8.14 Million | -25.78 Million | -6.74 Million | -4.72 Million |
| Net Income | -7.04 Million | -9.15 Million | -8.14 Million | -25.78 Million | -6.74 Million | -4.72 Million |
| Earnings Per Share Basic | -0.18 | -0.27 | -0.26 | - | -0.22 | -0.16 |
| Earnings Per Share Diluted | -0.18 | -0.27 | -0.26 | - | -0.22 | -0.16 |
| Weighted Average Shares Outstanding | 40.06 Million | 33.73 Million | 30.77 Million | 30.02 Million | 30.36 Million | 29.61 Million |
| Weighted Average Shares Outstanding (Diluted) | 40.06 Million | 33.73 Million | 30.77 Million | 30.02 Million | 30.36 Million | 29.61 Million |
| Gross Margin | - | - | 0.82 | - | - | - |
| EBIT Margin | - | - | -40.65 | - | - | - |
| Profit Margin | - | - | -21.88 | - | - | - |
| EBITDA | -14.61 Million | -14.04 Million | -15.12 Million | - | -6.68 Million | -4.65 Million |
| Earnings Before Tax Margin | - | - | -40.83 | - | - | - |
FMK
OMED
CSCCF
CYDVF
SIIS
LUMAXIND